CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®) in Taiwan for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome (ALGS) ...Middle East

LIVMARLI is the First and Only Treatment Approved in Taiwan for Cholestatic Pruritus in ALGS LIVMARLI is approved for Cholestatic Pruritus in ALGS in the US, Canada, Europe, Mainland China, and other regions globally BEIJING and BURLINGTON, Mass., Oct. 8, 2023 /PRNewswire/ -- CANbridge...

Hence then, the article about canbridge announces marketing approval of can108 livmarli in taiwan for the treatment of cholestatic pruritus in patients with alagille syndrome algs was published today ( Monday 09/10/2023 - 03:08 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®) in Taiwan for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome (ALGS) )

Also on site :

• Bessent’s $4 billion bond plan is like ‘rearranging deckchairs on the Titanic given the U.S. national debt of $40 trillion,’ ING says
• Walmart’s Rustic 5-Tier Bookcase Brimming With Farmhouse Charm Is Perfect for Book Lovers and Plant Parents
• 1990 No. 1 Garth Brooks Hit, Reimagined by a Rising Star, Ranked Among the ‘Greatest Country Songs of All Time’